Recombinant multi-species DDX21 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DDX21 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
DEAD box proteins, characterized by the conserved motif Asp-Glu-Ala-Asp (DEAD), are putative RNA helicases. They are implicated in a number of cellular processes involving alteration of RNA secondary structure such as translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on their distribution patterns, some members of this family are believed to be involved in embryogenesis, spermatogenesis, and cellular growth and division. This gene encodes a DEAD box protein, which is an antigen recognized by autoimmune antibodies from a patient with watermelon stomach disease. This protein unwinds double-stranded RNA, folds single-stranded RNA, and may play important roles in ribosomal RNA biogenesis, RNA editing, RNA transport, and general transcription. [provided by RefSeq, Jul 2008]
The Alternative Names of target: D10Ertd645e,D10Wsu42e,DDX21,DEAD box protein 21,Ddx21,Ddx21a,Ddx21b,GUA,GURDB,Gu-alpha,II/Gu,Nucleolar RNA helicase 2,Nucleolar RNA helicase Gu,Nucleolar RNA helicase II,RH,RH II/Gu,RH-II/GU,RH-II/GuA,gu-alpha

Target products collectionGo to DDX21 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP13572-Ag-1/ GM-Tg-hg-IP13572-Ag-2 Human DDX21 protein Human
GM-Tg-rg-IP13572-Ag-1/ GM-Tg-rg-IP13572-Ag-2 Rat DDX21 protein Rat
GM-Tg-mg-IP13572-Ag-1/ GM-Tg-mg-IP13572-Ag-2 Mouse DDX21 protein Mouse
GM-Tg-cynog-IP13572-Ag-1/ GM-Tg-cynog-IP13572-Ag-2 Cynomolgus/Rhesus macaque DDX21 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP13572-Ag-1/ GM-Tg-felg-IP13572-Ag-2 Feline DDX21 protein Feline
GM-Tg-cang-IP13572-Ag-1/ GM-Tg-cang-IP13572-Ag-2 Canine DDX21 protein Canine
GM-Tg-bovg-IP13572-Ag-1/ GM-Tg-bovg-IP13572-Ag-2 Bovine DDX21 protein Bovine
GM-Tg-equg-IP13572-Ag-1/ GM-Tg-equg-IP13572-Ag-2 Equine DDX21 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP13572-Ag-1/ GM-Tg-hg-IP13572-Ag-2; GM-Tg-rg-IP13572-Ag-1/ GM-Tg-rg-IP13572-Ag-2;
GM-Tg-mg-IP13572-Ag-1/ GM-Tg-mg-IP13572-Ag-2; GM-Tg-cynog-IP13572-Ag-1/ GM-Tg-cynog-IP13572-Ag-2;
GM-Tg-felg-IP13572-Ag-1/ GM-Tg-felg-IP13572-Ag-2; GM-Tg-cang-IP13572-Ag-1/ GM-Tg-cang-IP13572-Ag-2;
GM-Tg-bovg-IP13572-Ag-1/ GM-Tg-bovg-IP13572-Ag-2; GM-Tg-equg-IP13572-Ag-1/ GM-Tg-equg-IP13572-Ag-2
Products Name DDX21 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DDX21
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DDX21 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.